In April, the Pharmaceutical Research and Manufacturers of America (PhRMA) elected AstraZeneca CEO David Brennan as its new chairman, a choice that bodes well for the future of healthcare and the pharmaceutical companies the organization represents.
In his more than three decades in the industry, Mr. Brennan has watched the companies he has worked for evolve and grow, and he has played a key role in moving some of those changes forward. He has been exposed to the complexities of an international industry, and he brings those global lessons to not only his company but the industry organization. He learned early on the value of medicine and the importance of acting honorably and with integrity. These are just a few of the many attributes he brings to his leadership roles at AstraZeneca and PhRMA.
The Makings of a Leader
Healthcare Reform: Getting it Right
Key actions to achieve reform that benefit patients and reduce costs